questionText: To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the potential impact of making Apolipoprotein M available through the NHS on the prevention of macular degeneration.
answerText: The Department has not made an assessment. There are no approved medicinal products in the United Kingdom with apolipoprotein M, and there is no specifically approved product for macular degeneration that is known to act mainly by increasing apolipoprotei...
heading: Macular Degeneration: Apolipoprotein M